相关实验视频

Updated: Sep 10, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

作为宿主免疫和癌症免疫治疗标准的siRNA:调节因子和基于纳米结合物的干预方法

Rahul Bhattacharjee¹, Debanjan Das¹, Srija Chakraborty²

¹KIIT School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT-DU), Bhubaneswar, Odisha, India.

International journal of biological sciences

|August 27, 2025

概括

与纳米颗粒结合的小干扰RNA (siRNA) 通过静止多药耐药基因提供有针对性的癌症治疗. 这种方法提高了治疗特异性,控制了瘤的进展,并减少了潜在的免疫反应和副作用.

科学领域:

癌症学
纳米技术
分子生物学

背景情况:

小干扰RNA (siRNA) 是癌症治疗中的关键RNA干扰 (RNAi).
纳米颗粒在临床瘤学中作为siRNA传递的有效载体.
基于纳米的siRNA结合物向多药性耐药性 (MDR) 基因,增强治疗特异性和瘤控制.

研究的目的:

审查siRNA输入对免疫细胞和控制因素的影响.
讨论影响siRNA-纳米结合物的瘤回归效率的局限性.
探索siRNA纳米结合剂治疗癌症的临床前和临床意义.

主要方法:

在癌症治疗中对siRNA纳米结合物的临床前研究的综述.
对siRNA传递机制和基因沉默效应的分析.
对纳米结合siRNA疗法的宿主免疫系统反应的评估.

主要成果:

在癌细胞中,siRNA纳米结合物对化疗耐药性的有效性得到了证明.
组合方法可以诱导宿主免疫反应并中和MDR基因.
临床前数据支持siRNA纳米结合物的疗效提高瘤回归.

结论:

siRNA纳米结合物治疗显示出抗癌应用的显著潜力.
了解siRNA与免疫细胞的相互作用对于优化治疗至关重要.
这一综述强调了siRNA结合物的转化潜力.

关键词:

癌症纳米结合物 siRNA 其他

更多相关视频

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

相关概念视频

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.